Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
BelgiumStudy on Safety and Efficacy of Bepirovirsen and Drug Combination for Chronic Hepatitis B in Patients on Nucleos(t)ide Analogue Therapy
BelgiumStudy of Pariglasgene Brecaparvovec and Prednisolone for Adults with Glycogen Storage Disease Type Ia
DenmarkStudy on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis
BelgiumStudy on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis
FranceStudy on the Safety and Effects of mRNA-3745 for Patients with Glycogen Storage Disease Type 1a (GSD1a)
FranceStudy on the Effects of VS-01 for Adults with Acute-on-Chronic Liver Failure and Ascites
BelgiumStudy of Tremelimumab, Durvalumab, and Drug Combination for Patients with Advanced Liver Cancer
IrelandStudy of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer
BulgariaStudy of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
GermanyStudy of Atezolizumab and Bevacizumab for Patients with High-Risk Hepatocellular Carcinoma After Surgery or Ablation
AustriaStudy on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid
BelgiumThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
